Erythrocyte thiopurine methyltransferase activity in a Korean population

被引:19
作者
Jang, IJ
Shin, SG
Lee, KH
Yim, DS
Lee, MS
Koo, HH
Kim, HK
Sohn, DR
机构
[1] SEOUL NATL UNIV,COLL MED & HOSP,DEPT PHARMACOL,SEOUL,SOUTH KOREA
[2] SEOUL NATL UNIV,COLL MED & HOSP,CLIN PHARMACOL UNIT,SEOUL,SOUTH KOREA
[3] UNIV ULSAN,COLL MED,DEPT PREVENT MED,ULSAN 680749,SOUTH KOREA
[4] SAMSUNG MED CTR,DEPT PEDIAT,SEOUL,SOUTH KOREA
[5] SUNCHEONHYANG UNIV,DEPT CLIN PHARMACOL,SEOUL,SOUTH KOREA
关键词
polymorphism; thiopurine; methyltransferase;
D O I
10.1111/j.1365-2125.1996.tb00122.x
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Thiopurine methyltransferase (TPMT) is the enzyme responsible for the S-methylation of thiopurine drugs. The enzyme, present in human red blood cells (RBC), is known to exhibit genetic polymorphism and interethnic differences in its activity have been demonstrated. We have studied the role of TPMT polymorphism in Koreans and compared enzyme activity between this and other ethnic groups. In a population of 350 unrelated healthy Korean subjects TPMT activity showed a large interindividual variation ranging from 3.2 to 22.9 nmol ml(-1) packed RBC h(-1) with a median value of 12.0 and mode of 11.0 nmol ml(-1) packed RBC h(-1). The enzyme activity was higher in male subjects than that in female (median values; 12.2 vs 11.2, 95% confidence interval of the difference; -2.1, 4.0 nmol ml(-1) packed RBC h(-1)). All subjects had detectable TPMT activity, but contrary to previous reports in other ethnic groups, this was distributed unimodally. The median RBC TPMT activity was very similar to values found in Caucasian populations, higher than in Floridian blacks and lower than that of a Norwegian Saami population.
引用
收藏
页码:638 / 641
页数:4
相关论文
共 20 条
[1]   THIOPURINE METHYLTRANSFERASE - STRUCTURE-ACTIVITY-RELATIONSHIPS FOR BENZOIC-ACID INHIBITORS AND THIOPHENOL SUBSTRATES [J].
AMES, MM ;
SELASSIE, CD ;
WOODSON, LC ;
VANLOON, JA ;
HANSCH, C ;
WEINSHILBOUM, RM .
JOURNAL OF MEDICINAL CHEMISTRY, 1986, 29 (03) :354-358
[2]  
CHOCAIR PR, 1993, Q J MED, V86, P359
[3]   THE IMPORTANCE OF THIOPURINE METHYLTRANSFERASE ACTIVITY FOR THE USE OF AZATHIOPRINE IN TRANSPLANT RECIPIENTS [J].
CHOCAIR, PR ;
DULEY, JA ;
SIMMONDS, HA ;
CAMERON, JS .
TRANSPLANTATION, 1992, 53 (05) :1051-1056
[4]  
DANIEL WW, 1978, APPL NONPARAMETRIC S, P88
[5]   TESTING FOR BIMODALITY IN FREQUENCY-DISTRIBUTIONS OF DATA SUGGESTING POLYMORPHISMS OF DRUG-METABOLISM - HYPOTHESIS-TESTING [J].
JACKSON, PR ;
TUCKER, GT ;
WOODS, HF .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1989, 28 (06) :655-662
[6]   TESTING FOR BIMODALITY IN FREQUENCY-DISTRIBUTIONS OF DATA SUGGESTING POLYMORPHISMS OF DRUG-METABOLISM - HISTOGRAMS AND PROBIT PLOTS [J].
JACKSON, PR ;
TUCKER, GT ;
WOODS, HF .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1989, 28 (06) :647-653
[7]   THIOPURINE METHYLTRANSFERASE ACTIVITY IN A SAMPLE-POPULATION OF BLACK SUBJECTS IN FLORIDA [J].
JONES, CD ;
SMART, C ;
TITUS, A ;
BLYDEN, G ;
DORVIL, M ;
NWADIKE, N .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1993, 53 (03) :348-353
[8]   GENDER DIFFERENCE IN RED-BLOOD-CELL THIOPURINE METHYLTRANSFERASE ACTIVITY [J].
KLEMETSDAL, B ;
WIST, E ;
AARBAKKE, J .
SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION, 1993, 53 (07) :747-749
[9]   INTERETHNIC DIFFERENCE IN THIOPURINE METHYLTRANSFERASE ACTIVITY [J].
KLEMETSDAL, B ;
TOLLEFSEN, E ;
LOENNECHEN, T ;
JOHNSEN, K ;
UTSI, E ;
GISHOLT, K ;
WIST, E ;
AARBAKKE, J .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1992, 51 (01) :24-31
[10]   THIOPURINE S-METHYLTRANSFERASE ACTIVITY IN A CHINESE POPULATION [J].
LEE, EJD ;
KALOW, W .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1993, 54 (01) :28-33